1-20 of 135
Sort by
News

Pacritinib Response Linked to Survival in Myelofibrosis With Thrombocytopenia

Katie Robinson
Published: 2025
Abstract
March 2025
View News titled, Pacritinib Response Linked to Survival in Myelofibrosis With Thrombocytopenia
News

Post-Transplant Mutation Clearance Important Indicator of Prognosis for Myelofibrosis

Leah Lawrence
Published: 2025
Abstract
April 2025
View News titled, Post-Transplant Mutation Clearance Important Indicator of Prognosis for Myelofibrosis
News

Azacitidine Plus Venetoclax May Offer Path to HCT for Patients with High-Risk Treatment-Naïve Myelodysplastic Syndromes

Khylia Marshall
Published: 2025
Abstract
March 2025
View News titled, Azacitidine Plus Venetoclax May Offer Path to HCT for Patients with High-Risk Treatment-Naïve Myelodysplastic Syndromes
News

Study Illuminates Clinical Characteristics, Molecular Origin of Post-CAR-T Treatment–Related Myeloid Neoplasms

Katie Robinson
Published: 2025
Abstract
February 2025
View News titled, Study Illuminates Clinical Characteristics, Molecular Origin of Post-CAR-T Treatment–Related Myeloid Neoplasms
News

IL-1β Inhibitor Canakinumab May Be Effective in Specific Genetic Subsets of Lower-Risk MDS

Leah Lawrence
Published: 2025
Abstract
February 2025
View News titled, IL-1β Inhibitor Canakinumab May Be Effective in Specific Genetic Subsets of Lower-Risk MDS
News

Revised Cytoreductive Start Criteria in PV Identify Thrombotic Risk Regardless of Conventional Risk Category

Katie Robinson
Published: 2024
Abstract
January 2025
View News titled, Revised Cytoreductive Start Criteria in PV Identify Thrombotic Risk Regardless of Conventional Risk Category
News

Findings Indicate TP53 Alterations Play a Significant Role in Myeloproliferative Neoplasm Disease Progression

Khylia Marshall
Published: 2024
Abstract
January 2025
View News titled, Findings Indicate TP53 Alterations Play a Significant Role in Myeloproliferative Neoplasm Disease Progression
News

Rusfertide Shows Durable Control of Hematocrit in Patients With Polycythemia Vera

Khylia Marshall
Published: 2024
Abstract
January 2025
View News titled, Rusfertide Shows Durable Control of Hematocrit in Patients With Polycythemia Vera
News

Study Reveals Prognostic Implications of Pulmonary Hypertension in MPN

Lara C. Pullen, PhD
Published: 2024
Abstract
January 2025
View News titled, Study Reveals Prognostic Implications of Pulmonary Hypertension in MPN
News

Elritercept May Provide Clinically Meaningful Benefits for Patients with MF

Lara C. Pullen, PhD
Published: 2024
Abstract
January 2025
View News titled, Elritercept May Provide Clinically Meaningful Benefits for Patients with MF
News

BOREAS: MDM2 Inhibitor Treats R/R Myelofibrosis Better Than Best Available Therapy

Leah Lawrence
Published: 2024
Abstract
January 2025
View News titled, BOREAS: MDM2 Inhibitor Treats R/R Myelofibrosis Better Than Best Available Therapy
News

Drawing First Blood: How Long Should Patients With a Myeloproliferative Neoplasm Be Anticoagulated?

Leah Lawrence
Published: 2024
Abstract
December 2024
View News titled, Drawing First Blood: How Long Should Patients With a Myeloproliferative Neoplasm Be Anticoagulated?
News

CHIP-Driver Genes Confer Variable Risk for Progression to Therapy-Related Myeloid Neoplasms

Leah Lawrence
Published: 2024
Abstract
Mid-November 2024
View News titled, CHIP-Driver Genes Confer Variable Risk for Progression to Therapy-Related Myeloid Neoplasms
News

Future of First-in-Class Roxadustat for Lower-Risk MDS Remains Uncertain

Leah Lawrence
Published: 2024
Abstract
October 2024
View News titled, Future of First-in-Class Roxadustat for Lower-Risk MDS Remains Uncertain
News

Molecular Taxonomy of MDS May Help Guide Clinical Decisions, Trials

Katie Robinson
Published: 2024
Abstract
September 2024
View News titled, Molecular Taxonomy of MDS May Help Guide Clinical Decisions, Trials
News

Decision Support System Defines Optimal Transplant Timing for Patients with Myelodysplastic Syndromes

Anna Azvolinsky, PhD
Published: 2024
Abstract
August 2024
View News titled, Decision Support System Defines Optimal Transplant Timing for Patients with Myelodysplastic Syndromes
News

Study of Patients with Myelodysplastic Syndromes Questions Need for Induction Therapy Before AlloHCT

Anna Azvolinsky, PhD
Published: 2024
Abstract
August 2024
View News titled, Study of Patients with Myelodysplastic Syndromes Questions Need for Induction Therapy Before AlloHCT
News

Safety of Oral Azacytidine in Patients With Lower-Risk MDS Consistent With Prior Results

Anna Azvolinsky, PhD
Published: 2024
Abstract
Mid-July 2024
View News titled, Safety of Oral Azacytidine in Patients With Lower-Risk MDS Consistent With Prior Results
News

Imetelstat Produces RBC Transfusion Independence in Lower-Risk Myelodysplastic Syndromes

Thomas R. Collins
Published: 2024
Abstract
March 2024
View News titled, Imetelstat Produces RBC Transfusion Independence in Lower-Risk Myelodysplastic Syndromes
News

Vibecotamab Shown to Be Effective Treatment for MDS, CMML

Lara C. Pullen, PhD
Published: 2023
Abstract
January 2024
View News titled, Vibecotamab Shown to Be Effective Treatment for MDS, CMML